Dr. Melissa E. Elder, MD

Dr. Elder practices at UF Health Shands Hospital in Gainesville, Florida, part of UF Health.

Dr. Elder's NPI, 1659328912, was assigned on May 30, 2006. Dr. Elder graduated from University Of Florida College Of Medicine in 1986. Dr. Elder holds Florida license ME92713.

Dr. Elder's primary practice is UF Health Shands Hospital, at 1600 SW Archer Rd, Gainesville, FL 32610 in Alachua County. The practice phone is (352) 265-8000.

Dr. Elder's primary practice is UF Health Shands Hospital in Gainesville, Florida, part of UF Health. The medical group on file is UF Health Physicians.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Elder practices. Vendor and product names are available with a free account.

Pediatric rheumatology is Dr. Elder's primary specialty in the NPI Registry, under taxonomy code 2080P0216X. Dr. Elder is board certified in pediatric rheumatology by the American Board of Pediatrics. Dmand AI has Dr. Elder's licenses on file in 2 states: Florida and California.

Dmand AI lists intellectual and developmental disabilities and skin cyst among the conditions Dr. Elder treats.

CMS data shows 40 Medicare services from Dr. Elder across 1 procedure code in 2024, all of them office visits, for 20 Medicare patients. Medicare paid $5,190 for them. Every service was in an office.

CMS counts 20 Medicare patients who saw Dr. Elder in 2024. The largest group is under 65, with 20 patients. 55% of them have arthritis, and 55% have high blood pressure. Their average risk score is 2.93, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Elder's median patient age at 19, with 46% women.

In 2024, Dr. Elder wrote 13 Medicare Part D claims. CMS names the drug for 12 of them, across 1 drug with 11 or more claims each, at $51,288 in total drug cost. In 2021, CMS named 13 claims across 1 drug.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 48 out of 100 for Dr. Elder for performance year 2024, reported through an alternative payment model (APM). Dr. Elder accepts Medicare assignment, so Medicare's approved amount is taken as full payment.

Dmand AI links 46 papers to Dr. Elder, published from 2000 to 2025. 2024 was the busiest year, with 4. The most frequent topics are Autoantibodies, Immunosuppressive Agents and Lymphocyte Activation. Dr. Elder has published most often in J Immunol. Dr. Elder's most frequent co-authors are Barry J. Byrne, MD, Noel K. Maclaren, MD and Renee F. Modica, MD.

Dmand AI links Dr. Elder to 4 clinical trials. 1 is still active or recruiting. Conditions studied include Glycogen Storage Disease Type II, Glycogen Storage Disease and Arthritis, Juvenile. University of Florida sponsors the most, 2. Open Payments lists research payments to Dr. Elder that name 1 trial.

CMS Open Payments shows 40 general payments to Dr. Elder from 12 drug and device companies from 2016 to 2024. Food and beverage make up the largest share, 100% of the total. Abbvie Inc. paid the most, $698. It also lists 2 research payments totaling $59,813 in 2025, naming 1 clinical trial.

Dmand AI lists 2 awards for Dr. Elder, most recently Top Doctor in 2018.

Dr. Elder graduated from University Of Florida College Of Medicine in 1986. Dr. Elder is a member of ACR.

Dr. Elder is in network with 15 carriers, including Aetna, United Healthcare and Blue Cross Blue Shield of Michigan. PPO plans come from the most carriers, 9. Check the plan with the practice before a visit.